HLN
Haleon·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 2
EPS Beats Expectation
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About HLN
Haleon Plc
A global leader in consumer health that develops, manufactures, and sale of various consumer healthcare products
Healthcare Providers and Services
10/20/2021
07/22/2022
New York Stock Exchange
24,561
12-31
Depository Receipts (Ordinary Shares)
Building 5, First Floor, The Heights, Weybridge, KT13 0NY, United Kingdom
--
Haleon Plc was incorporated in England and Wales on October 20, 2021 and is a private limited company. The company focuses on consumer healthcare. The Group is a global leader in consumer healthcare and a leader in OTC, VMS and therapeutic oral health sales. The Group's portfolio of category leading brands includes the world's number one sensitive toothpaste, the world's leading multivitamin, the world's leading topical pain relief brand, the world's leading denture care brand and a series of other large well-known consumer health care brands with global or regional leading positions.
Earnings Call
Q2/2025
Estimate EPS--
Actual EPS--
Estimate Revenue3.49B
Actual Revenue--
Haleon's Q2 2025 Earnings Call: Unraveling Contradictions in North America Sales and Market Performance
Jul 31,2025 08:07
Earnings Decrypt
Earnings Decrypt
Company Financials
Revenue & Expenses
HLN has released its 2024 Q4 earnings report, with revenue of 3.45B, reflecting a YoY change of -1.99%, and net profit of 277.97M, showing a YoY change of 3016.18%. The Sankey diagram below clearly presents HLN's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
